An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Top results in this bookTable of Contents
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Clinical Review Report: Cysteamine 3.8 mg/mL ophthalmic solution (Cystadrops): (Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits in adults and children from two years of age with cystinosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul.
Pharmacoeconomic Review Report: Cysteamine 3.8 mg/mL Ophthalmic Solution (Cystadrops): (Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits in adults and children from two years of age with cystinosis [Internet].
Webvision: The Organization of the Retina and Visual System [Internet].
Kolb H, Fernandez E, Jones B, et al., editors.
Salt Lake City (UT): University of Utah Health Sciences Center; 1995-.
Clinical Review Report: Preservative-free latanoprost 50 μg/mL ophthalmic solution (Monoprost): (Laboratoires Théa): Indication: Reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 May.
Clinical Review Report: Voretigene Neparvovec (Luxturna): (Novartis Pharmaceuticals Canada Inc.): Indication: Vision loss, inherited retinal dystrophy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Jan.
Toxicological Profile for Sulfur Mustard.
Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2003 Sep.
Clinical Review Report: Cyclosporine (VERKAZIA): (Santen Canada Inc.): Indication: Treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.
Galcanezumab (Emgality): CADTH Reimbursement Review: Therapeutic area: Prevention of migraine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition.
Walker HK, Hall WD, Hurst JW, editors.
Boston: Butterworths; 1990.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Visual Dysfunction in Patients with Traumatic Brain Injury: A Systematic Review [Internet].
O'Neil M, Gleitsmann K, Motu'apuaka M, et al.
Washington (DC): Department of Veterans Affairs (US); 2014 Sep.
Self-Administered Drug Treatments for Acute Migraine Headache.
Gray RN, McCrory DC, Eberlein K, et al.
Rockville (MD): Agency for Health Care Policy and Research (US); 1999 Feb. (Technical Reviews, No. 2.4.)
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Developmental follow-up of children and young people born preterm.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Aug. (NICE Guideline, No. 72.)
Acute Treatments for Episodic Migraine [Internet].
Singh RBH, VanderPluym JH, Morrow AS, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec. (Comparative Effectiveness Review, No. 239.)
Medical Microbiology. 4th edition.
Baron S, editor.
Galveston (TX): University of Texas Medical Branch at Galveston; 1996.
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2024 Mar 19. (NICE Guideline, No. 240.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on